User profiles for C. Perno

Carlo Federico Perno

Università di Milano
Verified email at uniroma2.it
Cited by 25773

European guidelines on the clinical management of HIV-1 tropism testing

…, T Klimkait, K Korn, B Masquelier, CF Perno… - The Lancet infectious …, 2011 - thelancet.com
… Group C studies evaluated the performance of different tropism tests in plasma samples
of … Enhanced sensitivity Trofile assay: XTrack C /PhenX-R (combination of genotypic and …

Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir

…, R Caliò, J Balzarini, MC Bellocchi, E Garaci, CF Perno - Antiviral research, 2002 - Elsevier
Cells of macrophage lineage represent a key target of human immunodeficiency virus (HIV)
in addition to CD4-lymphocytes. The absolute number of infected macrophages in the body …

[HTML][HTML] HIV-1 genetic variability and clinical implications

MM Santoro, CF Perno - International Scholarly Research Notices, 2013 - hindawi.com
… As already known, several studies have shown that, among non-B subtypes, subtypes C and
D were found to be more aggressive in terms of disease progression. Luckily, the response …

Highly active antiretroviral therapy reduces the age-associated risk of dementia in a cohort of older HIV-1-infected patients

…, A Ammassari, V Tozzi, CF Perno… - AIDS Research & …, 2006 - liebertpub.com
Historically, older patients have shown a higher risk of HIV-1-associated dementia (HIVD).
The objective of this study was to evaluate the association of aging with HIVD and minor …

1, 2, 3-Triazole-[2, 5-Bis-O-(tert-butyldimethylsilyl)-. beta.-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'', 2''-oxathiole 2'', 2''-dioxide)(TSAO) Analogs: Synthesis and Anti-HIV …

…, S Aquaro, ED Clercq, CF Perno… - Journal of medicinal …, 1994 - ACS Publications
… As a rule, there were no striking differences in the antiviral activity of the substituted 1,2,3-triazole-TSAO
derivatives with the substituent present in the C-4, as compared to the C-5, …

Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative

…, J Balzarini, D Schols, H Nakashima, CF Perno… - Biochemical and …, 1989 - Elsevier
A novel 6-substituted acyclouridine derivative, 1-[(2-hydroxy-ethoxy) methyl]-6-phenylthiothymine
(HEPT), has proved to be a potent and selective inhibitor of human immunodeficiency …

Multicenter evaluation of the cepheid Xpert Xpress SARS-CoV-2 test

…, SM Butler-Wu, U Pandey, CF Perno… - Journal of clinical …, 2020 - Am Soc Microbiol
Nucleic acid amplification tests (NAATs) are the primary means of identifying acute infections
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Accurate and …

[HTML][HTML] Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

…, C Sabin, I Mukui, MM Santoro, CF Perno… - The Lancet infectious …, 2016 - thelancet.com
… Lastly, our data tended to be consistent with previous studies—eg, our findings of higher
resistance in subtype C patients are consistent with in-vitro data suggesting subtype C viruses …

Cytomegalovirus coinfection is associated with an increased risk of severe non–AIDS-defining events in a large cohort of HIV-infected patients

…, G Ippolito, A Lazzarin, CF Perno… - The Journal of …, 2015 - academic.oup.com
Background Chronic cytomegalovirus (CMV) infection has been associated with immunosenescence
and immunoactivation in the general population. In human immunodeficiency virus …

[PDF][PDF] Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections

…, EP Mortari, MR Vinci, C Russo, C Alteri, C Albano… - Cell host & …, 2022 - cell.com
Breakthrough SARS-CoV-2 infections in fully vaccinated individuals are considered a
consequence of waning immunity. Serum antibodies represent the most measurable outcome of …